Comparison between serology and histology in the diagnosis of advanced gastric body atrophy: A study in a Dutch primary community

Journal of Clinical Gastroenterology

Volumn 42, Issue 1, 2008, Pages 18-22

  Korstanje, André ^a   Eeden, Susanne Van ^a   Offerhaus, Johan A ^a   Waltman, Frans L ^b   Hartog, Gijsbert Den ^c   Roelandse, Freek W C ^d   Souverijn, John H M ^d   Biemond, Izak ^d   Lamers, Cornelis B H W ^d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Oosterschelde Hospital   (Netherlands)

^c RIJNSTATE HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Gastric body atrophy; Gastrin; Pepsinogen; Primary care; Serum biopsy

Indexed keywords

BIOLOGICAL MARKER; GASTRIN; PEPSINOGEN;

ADULT; ARTICLE; ATROPHIC GASTRITIS; CLINICAL ARTICLE; FEMALE; GENERAL PRACTICE; HISTOLOGY; HUMAN; HYPERGASTRINEMIA; MALE; NETHERLANDS; PERFORMANCE; PRIORITY JOURNAL; SEROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ATROPHY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOPSY; CHRONIC DISEASE; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY; FEMALE; GASTRIC FUNDUS; GASTRINS; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PEPSINOGENS; PREVALENCE; PYLORIC ANTRUM; SEROLOGIC TESTS;

EID: 37549068512     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000248008.70396.90     Document Type: Article

References (28)

1. Dixon M, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston. Am J Surg Pathol. 1996;20:1161-1181.
2. The Eurohepygast Study Group. Risk factors for chronic gastritis in a European population: results of the Eurohepygast study. Gut. 2002;50:779-785.
3. Kuipers EJ, Uyterlinde AM, Peňa AS, et al. Long term sequelae of Helicobacter pylori gastritis. Lancet. 1995;345:1525-1528.
4. Whitehead R. The classification of chronic gastritis: current status. J Clin Gastroenterol. 1995;21:S131-S134.
5. Kapadia CR. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective. J Clin Gastroenterol. 2003;36(suppl):S29-S36.
6. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-6740.
7. El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology. 2000;118:22-30.
8. Correa P. Is gastric cancer preventable? Gut. 2004;53:1217-1219.
9. Broutet N, Plebani M, Sakarovitch C, et al. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer. 2003;88:1239-1247.
10. Korstanje A, Hartog den G, Biemond I, et al. The serologic gastric biopsy: a non-endoscopical diagnostic approach in management of the dyspeptic patient. Scand J Gastroenterol. 2002;37(suppl 236):22-26.
11. Westerveld BD, Pals G, Lamers CBHW, et al. Clinical significance of pepsinogen A isozymogens, serum pepsinogens A and levels, and serum gastrin level. Cancer. 1987;59:952-958.
12. Borch K, Axelsson CK, Halgreen H, et al. The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol. 1989;24:870-876.
13. Väänänen H, Vauhkonen M, Helske T, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol. 2003;15:885-891.
14. Kuipers EJ. In through the out door: serology for atrophic gastritis. Eur J Gastroenterol Hepatol. 2003;15:877-879.
15. Biemond I, Jansen JBMJ, Crobach LFSJ, et al. Radioimmunoassay of human pepsinogen A and pepsinogen C. J Clin Chem Clin Biochem. 1989;27:19-25.
16. Peňa AS, Endtz HPh, Offerhaus GJ, et al. Value of serology (Elisa and Immunoblotting) for the diagnosis of Campylobacter pylori infection. Digestion. 1989;44:131-141.
17. Tytgat GN. The Sydney System: endoscopic division. Endoscopic appearances in gastritis/duodenitis. J Gastroenterol Hepatol. 1991;6:223-234.
18. Bins M, Burgers PI, Selbach SG, et al. Prevalence of achlorhydria in a normal population and its relation to serum gastrin. Hepatogastroenterol. 1984;31:41-43.
19. Annibale B, Negrini R, Caruana P, et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter. 2001;6:225-233.
20. Whittingham S, Mackray IR. Autoimmune gastritis: historical antecedents, outstanding discoveries, and unresolved problems. Int Rev Immun. 2005;24:1-29.
21. 13C-urea breath test and serology. Scand J Gastroenterol. 2000;35:138-141.
22. Testoni PA, Bonassi U, Bagnolo F, et al. In diffuse atrophic gastritis, routine histology underestimates Helicobacter infection. J Clin Gastroenterol. 2002;35:234-239.
23. Kokkola A, Rautelin H, Puolakkainen P, et al. Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis. J Clin Microbiol. 1998;36:1808-1810.
24. Kokkola A, Kosunen TU, Puolakkainen P, et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic gastritis. APMIS. 2003;111:619-624.
25. Faller G, Steiniger H, Kränzlein J, et al. Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis. Gut. 1997;41:619-623.
26. Appelmelk BJ, Faller G, Claeys D, et al. Bugs on trial: the case of Helicobacter pylori and autoimmunity. Immunol Today. 1998;19:296-299.
27. Amedei A, Bergman P, Appelmelk BJ, et al. Molecular mimicry between Helicobacter pylori antigens and H+, K+ -Adenosine triphosphatase in human gastric autoimmunity. J Exp Med. 2003;8:1147-1156.
28. Di Mario F, Moussa AM, Caruana P, et al. Serologic biopsy in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scand J Gastroenterol. 2003;38:1223-1227.